Latest News about why it's moving
Recent news which mentions why it's moving
Why Are Janover Stocks Surging On Friday?
April 11, 2025
From Benzinga
BlackRock's Bold Quarter: EPS Tops, $11.6 Trillion AUM, $84 Billion Inflows Power Growth
April 11, 2025
From Benzinga
'Economy Is Facing Considerable Turbulence:' JPMorgan Chase CEO Jamie Dimon Cautions About 'Negatives Of Tariffs And Trade Wars'
April 11, 2025
From Benzinga
Wells Fargo Doesn't Change Outlook But CEO Expects Volatility And Slower Economic Environment In 2025
April 11, 2025
From Benzinga
Gold Soars Beyond $3,200, ETFs Achieve Record Inflows In Q1
April 11, 2025
From Benzinga
From Benzinga
What's Going On With VinFast Auto Stock On Thursday?
April 10, 2025
From Benzinga
Health Care Technology Stocks Surge After FDA Announces Plans To Phase Out Animal Testing Requirements
April 10, 2025
From Benzinga
From Benzinga
From Benzinga
Oklo Stock Spikes Ahead Of The Close: Here's What Happened
April 10, 2025
From Benzinga
Hardware, Tech Stocks Fall As Markets Pull Back From Tariff-Driven Rally: What's Going On?
April 10, 2025
From Benzinga
Microsoft At Heart Of 'Tariff Armageddon': Analyst Flags Deal Delays, Expects Fallout To Hit Upcoming Earnings Season
April 10, 2025
From Benzinga
From Benzinga
From Benzinga
Janover Stock Soars After Company Acquires Solana Under New Treasury Strategy: What's Going On?
April 10, 2025
From Benzinga
Amazon and McDonald's Lead XLY Pullback As Consumer Stocks Dip After Tariff-Driven Rally
April 10, 2025
From Benzinga
Why Marin Software (MRIN) Stock Is Down 50%
April 10, 2025
From Benzinga
From Benzinga
BofA Slashes Delta Air Lines Estimates For 2025 And Beyond Amid Capacity, Revenue Challenges
April 10, 2025
From Benzinga
From Benzinga
FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch
April 10, 2025
From Benzinga
From Benzinga
From Benzinga
What's Going On With Willis Towers Watson Stock On Thursday?
April 10, 2025
From Benzinga
Tempest Weighs M&A, Analyst Sees A "Broken Story" Despite Phase 2 Liver Cancer Study Success
April 10, 2025
From Benzinga
ITT Q1 Preliminary Results: Flat Revenue, Eyes $1 Billion In Orders, $500 Million In New Buybacks & More
April 10, 2025
From Benzinga
From Benzinga
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.